X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Pfizer with IPCA Labs - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs IPCA LABS - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

IPCA LABS 
   Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER IPCA LABS PFIZER/
IPCA LABS
 
P/E (TTM) x 24.3 28.0 86.9% View Chart
P/BV x 3.9 2.1 180.3% View Chart
Dividend Yield % 0.8 0.2 349.7%  

Financials

 PFIZER   IPCA LABS
EQUITY SHARE DATA
    PFIZER
Mar-16
IPCA LABS
Mar-17
PFIZER/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs2,724643 423.6%   
Low Rs1,611503 320.4%   
Sales per share (Unadj.) Rs440.9254.4 173.3%  
Earnings per share (Unadj.) Rs48.716.1 303.0%  
Cash flow per share (Unadj.) Rs75.829.8 254.5%  
Dividends per share (Unadj.) Rs15.001.00 1,500.0%  
Dividend yield (eoy) %0.70.2 396.5%  
Book value per share (Unadj.) Rs462.9194.6 238.0%  
Shares outstanding (eoy) m45.75126.20 36.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.92.3 218.3%   
Avg P/E ratio x44.535.7 124.9%  
P/CF ratio (eoy) x28.619.2 148.7%  
Price / Book Value ratio x4.72.9 159.0%  
Dividend payout %30.86.2 495.0%   
Avg Mkt Cap Rs m99,16372,300 137.2%   
No. of employees `0002.913.3 21.7%   
Total wages/salary Rs m2,7586,960 39.6%   
Avg. sales/employee Rs Th6,981.72,413.5 289.3%   
Avg. wages/employee Rs Th954.5523.2 182.4%   
Avg. net profit/employee Rs Th771.1152.4 505.8%   
INCOME DATA
Net Sales Rs m20,17032,106 62.8%  
Other income Rs m857226 379.9%   
Total revenues Rs m21,02832,332 65.0%   
Gross profit Rs m4,3104,448 96.9%  
Depreciation Rs m1,2391,730 71.6%   
Interest Rs m5241 2.2%   
Profit before tax Rs m3,9232,703 145.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m990-   
Tax Rs m1,794675 265.8%   
Profit after tax Rs m2,2282,028 109.9%  
Gross profit margin %21.413.9 154.2%  
Effective tax rate %45.725.0 183.1%   
Net profit margin %11.06.3 174.9%  
BALANCE SHEET DATA
Current assets Rs m16,29917,340 94.0%   
Current liabilities Rs m7,5949,559 79.4%   
Net working cap to sales %43.224.2 178.1%  
Current ratio x2.11.8 118.3%  
Inventory Days Days65100 65.1%  
Debtors Days Days2657 45.3%  
Net fixed assets Rs m8,62220,779 41.5%   
Share capital Rs m458252 181.3%   
"Free" reserves Rs m20,72224,499 84.6%   
Net worth Rs m21,18024,553 86.3%   
Long term debt Rs m253,517 0.7%   
Total assets Rs m29,13739,595 73.6%  
Interest coverage x755.512.2 6,179.3%   
Debt to equity ratio x00.1 0.8%  
Sales to assets ratio x0.70.8 85.4%   
Return on assets %7.75.7 133.7%  
Return on equity %10.58.3 127.3%  
Return on capital %19.010.5 181.1%  
Exports to sales %0.148.6 0.1%   
Imports to sales %17.514.2 122.8%   
Exports (fob) Rs m1215,617 0.1%   
Imports (cif) Rs m3,5264,571 77.1%   
Fx inflow Rs m5215,617 0.3%   
Fx outflow Rs m1405,828 2.4%   
Net fx Rs m-889,790 -0.9%   
CASH FLOW
From Operations Rs m3,4362,764 124.3%  
From Investments Rs m-6,991-1,432 488.3%  
From Financial Activity Rs m-619-1,591 38.9%  
Net Cashflow Rs m-4,174-259 1,612.6%  

Share Holding

Indian Promoters % 0.0 45.9 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 11.4 65.8%  
FIIs % 4.9 25.3 19.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 17.4 136.2%  
Shareholders   85,207 36,892 231.0%  
Pledged promoter(s) holding % 0.0 2.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   GLENMARK PHARMA  FULFORD INDIA  MERCK LTD  DIVIS LABORATORIES  UNICHEM LAB  

Compare PFIZER With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Coal India Stock Rallies 4.2%(Closing)

Indian share markets finished some selling pressure in the final hour of trade to finish flat amid weak European markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Aug 17, 2017 (Close)

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS